DG
12
2
DTE
38
-4
HUM
48
2
ETR
68
-3
FLR
48
3
VLO
42
2
FTI
78
-3
CI
52
-7
BK
72
-2
DIS
62
2
LOW
58
2
KLAC
45
-4
NI
73
3
CHD
48
-3
UPS
50
9
EW
32
3
SRE
66
-3
PG
50
2
CSX
68
3
NKE
33
2
DG
12
2
DTE
38
-4
HUM
48
2
ETR
68
-3
FLR
48
3
VLO
42
2
FTI
78
-3
CI
52
-7
BK
72
-2
DIS
62
2
LOW
58
2
KLAC
45
-4
NI
73
3
CHD
48
-3
UPS
50
9
EW
32
3
SRE
66
-3
PG
50
2
CSX
68
3
NKE
33
2
Financhill
Back

Skye Bioscience Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
42

SKYE
Skye Bioscience

Last Price:
5.63
Seasonality Move:
51.7%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Skye Bioscience Price Quote

$5.63
+0.31 (+5.83%)
(Updated: November 14, 2024 at 12:30 PM ET)

Skye Bioscience Key Stats

Sell
42
Skye Bioscience (SKYE) is a Sell
Day range:
$5.16 - $5.51
52-week range:
$1.44 - $19.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
403.50
P/B ratio:
2.25%
Volume:
117.1K
Avg. volume:
234.1K
1-year change:
212.94%
Market cap:
$163.5M
Revenue:
$0
EPS:
$-3.91

How Much Does Skye Bioscience Make?

Data Unavailable

Is Skye Bioscience Growing As A Company?

Data Unavailable

Skye Bioscience Stock Price Performance

  • Did Skye Bioscience Stock Go Up Last Month?
    Skye Bioscience share price went up by 24.01% last month
  • Did SKYE's Share Price Rise Over The Last Year?
    SKYE share price rose by 212.94% over the past 1 year

What Is Skye Bioscience 52-Week High & Low?

Skye Bioscience Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Skye Bioscience?

  • How Much Debt Does Skye Bioscience Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Skye Bioscience Have?
    Cash and short term investments quarterly total is $74.1M
  • What Is Skye Bioscience’s Book Value Per Share?
    Book value per share is 2.59

Is Skye Bioscience Cash Flow Positive?

  • What Is SKYE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$19.7M
  • What Is Skye Bioscience’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $100.2M
  • What Is Skye Bioscience’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $2.2M

Skye Bioscience Return On Invested Capital

Data Unavailable

Skye Bioscience Earnings Date & Stock Price

Skye Bioscience Competitors

  • Who Are Skye Bioscience's Competitors?
    Below is a list of companies who compete with Skye Bioscience or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oramed Pharmaceuticals Inc (ORMP)
    • Palatin Technologies Inc (PTN)
    • Viking Therapeutics Inc (VKTX)

Skye Bioscience Dividend Yield

Skye Bioscience Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 59.08%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 18.00
Upside from Last Price: 238.35%

Major Shareholders

  • How many SKYE shares are owned by institutional investors?
    532.2M SKYE shares are owned by institutional investors
  • How many SKYE shares are owned by insiders?
    8.5M SKYE shares are owned by insiders